Blood Clotting Factors Market Is Gaining Significant Traction With Novo Nordisk Receiving The U.S. Fda Approval For Its Biologics License Application The Treatment Of Hemophilia A
Blood clotting refers to the physiological process whereby red blood cells bind together with plasma (blood plasma) and stop the spread of blood from one vessel to another. Coagulation, or blood clotting, is normally the result of the thrombotic occlusion, whereby a blood clot forms in a blood vessel (venous thrombus) after it breaks, usually due to intense physical trauma or bleeding. Since there is a high yield of plasma products and has increasing number of patients with blood disorders, North America is likely to gain robust traction in the blood clotting factors market in the near future. On the contrary, Asia Pacific is exhibiting promising signs with improving healthcare infrastructure and rising disposable income in the region. Blood clotting factors play an immense role in control the bleeding wherein blood is converted into solid lots at the time of any wound or break down of blood vessels. Over the years, regulatory authorities have approved novel drugs for blood clot...